Blood test may help solve early puberty puzzle in girls

NCT ID NCT07359092

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at 143 girls to see if two natural chemicals in the blood, spexin and phoenixin-20, can help doctors tell the difference between true central precocious puberty and a harmless condition called premature thelarche. Researchers measured these chemicals in girls with early breast development and in healthy controls. The goal is to find a simple blood test that could guide diagnosis and avoid unnecessary treatments.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this research could lead to a simple blood test to help doctors tell the difference between central precocious puberty and harmless early breast development.
What could go wrong
This is a small, completed observational study, not a treatment trial. The findings need to be confirmed in larger, more diverse groups before any diagnostic test becomes available.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CENTRAL PRECOCIOUS PUBERTY (CPP) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Kayseri City Hospital

    Kayseri, 38080, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.